Mobile apps are an important link between researchers and patients, but using them in clinical development requires rigorous preparation to ensure data collected is useful for continued research and drug approval applications.
This white paper, "Mobile Apps: a 360° Guide For Clinical Trials" provides helpful considerations for sponsors and their CRO partners on this topic, including:
Data and regulatory aspects of a mobile app's role in clinical development
A better understanding of the current and future mobile app regulatory environment
Tailoring apps to meet backend data demands and ensure appropriate data collection
Learn how to develop a viable data strategy for active task and passive mobile apps throughout the trial life cycle, and provide new levels of insight and patient engagement.